CXCL10 (α) and CCL2 (β) chemokines in systemic sclerosis—a longitudinal study
Objectives. To measure serum levels of CXCL10 and CCL2 chemokines in patients with
SSc, and relate the findings to clinical phenotype and disease progression. Methods. Serum …
SSc, and relate the findings to clinical phenotype and disease progression. Methods. Serum …
CXCL10 ({alpha}) and CCL2 () chemokines in systemic sclerosis a longitudinal study.
A Antonelli, C Ferri, P Fallahi, SM Ferrari… - …, 2008 - search.ebscohost.com
Objectives. To measure serum levels of CXCL10 and CCL2 chemokines in patients with
SSc, and relate the findings to clinical phenotype and disease progression. Methods. Serum …
SSc, and relate the findings to clinical phenotype and disease progression. Methods. Serum …
[引用][C] CXCL10 () and CCL2 () chemokines in systemic sclerosis a longitudinal study
A Antonelli, C Ferri, P Fallahi, SM Ferrari, D Giuggioli… - Rheumatology, 2008 - cir.nii.ac.jp
CXCL10 (alpha) and CCL2 (beta) chemokines in systemic sclerosis-a longitudinal study
A Antonelli, C Ferri, P Fallahi, S Ferrari, D Giuggioli… - …, 2008 - arpi.unipi.it
Objectives. To measure serum levels of CXCL10 and CCL2 chemokines in patients with
SSc, and relate the findings to clinical phenotype and disease progression. Methods. Serum …
SSc, and relate the findings to clinical phenotype and disease progression. Methods. Serum …
[PDF][PDF] CXCL10 (a) and CCL2 (b) chemokines in systemic sclerosis—a longitudinal study
A Antonelli, C Ferri, P Fallahi, SM Ferrari, D Giuggioli… - Rheumatology, 2008 - Citeseer
Objectives. To measure serum levels of CXCL10 and CCL2 chemokines in patients with
SSc, and relate the findings to clinical phenotype and disease progression. Methods. Serum …
SSc, and relate the findings to clinical phenotype and disease progression. Methods. Serum …
CXCL10 (alpha) and CCL2 (beta) chemokines in systemic sclerosis--a longitudinal study
A Antonelli, C Ferri, P Fallahi… - Rheumatology …, 2008 - pubmed.ncbi.nlm.nih.gov
Objectives To measure serum levels of CXCL10 and CCL2 chemokines in patients with SSc,
and relate the findings to clinical phenotype and disease progression. Methods Serum …
and relate the findings to clinical phenotype and disease progression. Methods Serum …
CXCL10 ({alpha}) and CCL2 () chemokines in systemic sclerosis a longitudinal study
A Antonelli, C Ferri, P Fallahi, SM Ferrari, D Giuggioli… - Rheumatology, 2008 - elibrary.ru
Objectives. To measure serum levels of CXCL10 and CCL2 chemokines in patients with
SSc, and relate the findings to clinical phenotype and disease progression. Methods. Serum …
SSc, and relate the findings to clinical phenotype and disease progression. Methods. Serum …
CXCL10 (alpha) and CCL2 (beta) chemokines in systemic sclerosis--a longitudinal study.
A Antonelli, C Ferri, P Fallahi, SM Ferrari… - Rheumatology …, 2008 - europepmc.org
Objectives To measure serum levels of CXCL10 and CCL2 chemokines in patients with SSc,
and relate the findings to clinical phenotype and disease progression. Methods Serum …
and relate the findings to clinical phenotype and disease progression. Methods Serum …
CXCL10 (alpha) and CCL2 (beta) chemokines in systemic sclerosis--a longitudinal study.
A Antonelli, C Ferri, P Fallahi, SM Ferrari… - …, 2008 - iris.unimore.it
OBJECTIVES: To measure serum levels of CXCL10 and CCL2 chemokines in patients with
SSc, and relate the findings to clinical phenotype and disease progression. METHODS …
SSc, and relate the findings to clinical phenotype and disease progression. METHODS …
[引用][C] CXCL10 (α) and CCL2 (β) chemokines in systemic sclerosis: a longitudinal study
A ANTONELLI, C FERRI… - Rheumatology …, 2008 - pascal-francis.inist.fr
CXCL10 (α) and CCL2 (β) chemokines in systemic sclerosis : a longitudinal study CNRS Inist
Pascal-Francis CNRS Pascal and Francis Bibliographic Databases Simple search Advanced …
Pascal-Francis CNRS Pascal and Francis Bibliographic Databases Simple search Advanced …